(Q34620781)
Statements
Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas (English)
Joan Maurel
Ana Sofia Martins
Andrés Poveda
José Antonio López-Guerrero
Ricardo Cubedo
Antonio Casado
Javier Martínez-Trufero
Juan Ramón Ayuso
Antonio Lopez-Pousa
Xabier Garcia-Albeniz
Xavier Garcia del Muro